152 related articles for article (PubMed ID: 33554761)
1. High KIF11 expression is associated with poor outcome of NSCLC.
Liu J; Tian Y; Yi L; Gao Z; Lou M; Yuan K
Tumori; 2022 Feb; 108(1):40-46. PubMed ID: 33554761
[TBL] [Abstract][Full Text] [Related]
2. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
Tan J; Yang L
Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
[TBL] [Abstract][Full Text] [Related]
4. Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients.
Wang G; Wang Z; Yu H
J Clin Lab Anal; 2020 Apr; 34(4):e23135. PubMed ID: 31858647
[TBL] [Abstract][Full Text] [Related]
5. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
Rong B; Nan Y; Liu H; Gao W
Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
[TBL] [Abstract][Full Text] [Related]
8. KIF11, a plus end-directed kinesin, as a key gene in benzo(a)pyrene-induced non-small cell lung cancer.
Ling J; Wang Y; Ma L; Zheng Y; Tang H; Meng L; Zhang L
Environ Toxicol Pharmacol; 2022 Jan; 89():103775. PubMed ID: 34800719
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of Kinesin family in lung adenocarcinoma via integrated bioinformatics approach.
Tabassum G; Singh P; Gurung R; Hakami MA; Alkhorayef N; Alsaiari AA; Alqahtani LS; Hasan MR; Rashid S; Kumar A; Dev K; Dohare R
Sci Rep; 2023 Jun; 13(1):9859. PubMed ID: 37330525
[TBL] [Abstract][Full Text] [Related]
12. Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Li R; Gao Y; Qiu B; Tan F; Xue Q; Gao S; He J
DNA Cell Biol; 2020 Apr; 39(4):631-644. PubMed ID: 32096653
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
14. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer.
Neska-Długosz I; Buchholz K; Durślewicz J; Gagat M; Grzanka D; Tojek K; Klimaszewska-Wiśniewska A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575892
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-5702 is associated with clinical progression and poor prognosis in patients with non-small-cell lung cancer.
Li K; Xu Y; Yuan LN
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2047-2052. PubMed ID: 30915748
[TBL] [Abstract][Full Text] [Related]
17. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer].
Liu Q; Wang S; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868
[TBL] [Abstract][Full Text] [Related]
18. KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.
Hu ZD; Jiang Y; Sun HM; Wang JW; Zhai LL; Yin ZQ; Yan J
Biomed Res Int; 2021; 2021():2676745. PubMed ID: 33490265
[TBL] [Abstract][Full Text] [Related]
19. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
Deng B; Sun Z; Jason W; Yang P
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
